Article
Mesenchymal stem cell therapy for liver fibrosis.
The Korean journal of internal medicine - 1 Sept 2015
Eom Young Woo, Shim Kwang Yong, Baik Soon Koo
Abstract excerpt
Currently, the most effective treatment for end-stage liver fibrosis is liver transplantation; however, transplantation is limited by a shortage of donor organs, surgical complications, immunological rejection, and high medical costs. Recently, mesenchymal stem cell (MSC) therapy has been suggested as an effective alternate approach for the treatment of hepatic diseases. MSCs have the potential to differentiate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
